Company intelligence / Profile preview

Summer Road

New York, New York, United Statesnhtsa.gov ↗

Ownership: Private
Development stage: Other

Overview

Not a drug development or clinical-stage company; invests in various sectors including biotechnology through equity purchases[2].\nNo clinical results or pipeline.\nLed by David Sackler; associated with the Sackler family legacy from Purdue Pharma[1].\nHas invested in public biopharmaceutical companies such as Ocular Therapeutix ($OCUL)[2].\nNo evidence of direct R&D activities.\nNot listed among active or defunct biotech firms; not referenced as having its own therapeutic programs.

Industry: Investors

Beyond the preview

Go deeper on Summer Road.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Summer Road.

Explore the full profile